The 6th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), will focus on Cyclin-dependent kinases (CDKs).

It is the next important step in a strategic collaboration between basic scientists and translational and clinical researchers.

The aim is to foster close cooperation among academics, clinical and industry researchers in a highly interactive hands-on professional environment.

The Scientific Committee is composed of some of the world’s leading experts in modern cancer medicine. 

They work together to ensure you learn and discuss the most advanced approaches known to us today.